Riskpilot← Back to searchSign inGet full accessDermalab Lund AB
ABActiveOrg 5594133927Manufacture of perfume and toilet preparations · NACE 2042Est. 20220 employees
Revenue 2025
SEK -4K
0% vs 2024
EBITDA margin
100.0%
0% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -4K
0% vs 2024
| Revenue | SEK -4K | +0% |
| EBITDA | SEK -4K | +0% |
| Net profit | SEK -4K | +0% |
| Total assets | SEK 15K | -19% |
| Equity | SEK 15K | -19% |
| Employees | 0 | — |
Legal name
Dermalab Lund AB
Org number
5594133927
Legal form
Aktiebolag
NACE code
2042 · Manufacture of perfume and toilet preparations
Founded
19 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Erici, Ola Harald Wolffradt
Company purpose
Företaget skall utveckla, producera, marknadsföra och sälja kroppsvårdsprodukter samt ägna sig åt all annan därtill kopplad verksamhet. Företaget skall bedriva utbildning och konferenser inom hälsa och livsstil. Företaget skall förvalta fasta tillgångar.
Address
Email
ola@erici.org
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | −3 | −4 | −4 |
| Staff expenses | — | — | — |
| EBITDA | −3 | −4 | −4 |
| Depreciation & amort. | — | — | — |
| EBIT | −3 | −4 | −4 |
| Net financials | — | — | — |
| Profit before tax | −3 | −4 | −4 |
| Tax | — | — | — |
| Net profit | −3 | −4 | −4 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 22 | 19 | 15 |
| Equity | 22 | 19 | 15 |
| Long-term debt | — | — | — |
| Short-term debt | — | — | — |
| Total debt | — | — | — |
EBITDA margin
-360000.0%
This company
15.8%
Market median
-2278581% vs market
20232025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232025
Return on equity
-23.8%
This company
18.4%
Market median
-229% vs market
20232025
Net profit margin
-360000.0%
This company
8.1%
Market median
-4444544% vs market
20232025
Asset turnover
-0.24×
This company
1.12×
Market median
-121% vs market
20232025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2025 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Alogis AB
Dermalab Lund AB Board members of Dermalab Lund AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Fredrik Sundén | Board of Directors | 0 companies |
| Maja Ahnborg | Deputy Board Member | 0 companies |
| Ola Harald Wolffradt Erici | Chairman | 0 companies |
| Ulla Sophia André Klingspor | Board of Directors | 0 companies |
| Carl Ludvig Svartz | Deputy Board Member | 0 companies |
| Ewa Gisela A Ehrensvärd Erici | Deputy Board Member | 0 companies |